Authored By: Sarah
11 Jul 2024

 Pelvic Floor Diagnostics Market Size to grow by USD 161.81 million between 2024-2028

According to a research report “ Pelvic Floor Diagnostics Market” by Product (Ultrasound system, Uroflowmetry, Anorectal manometry system, Urodynamic catheters, Cystoscope and others) End-user (Hospital, Diagnostic imaging centers, specialized clinics) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 161.81 million, at a CAGR of  5.7% during the forecast period. The pelvic floor diagnostics market holds significant potential due to the increasing prevalence of pelvic floor disorders, particularly urinary incontinence. This condition, characterized by involuntary urine leakage, can be attributed to various factors, including age-related changes in the urinary tract and underlying health conditions such as cognitive impairment, stroke, diabetes, and mobility impairment. According to the CDC, the incontinence rate in individuals aged between 65-74 years is 26% for men and 55% for women, underscoring the need for advanced diagnostic tools to accurately identify and treat this condition. Pelvic floor disorders can significantly impact quality of life and lead to increased healthcare utilization and costs. Therefore, there is a pressing need for innovative diagnostics solutions to improve patient outcomes and reduce the economic burden of these conditions.

Browse market data tables, figures, and in-depth TOC on “Pelvic Floor Diagnostics Market” by Product (Ultrasound system, Uroflowmetry, Anorectal manometry system, Urodynamic catheters, Cystoscope and others) End-user (Hospital, Diagnostic imaging centers, specialized clinics) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample


By Product, the Ultrasound system segment is projected to dominate the market size in 2024

Hospitals, as significant end-users, significantly influence the expansion of the pelvic floor diagnostic market. These institutions include multispecialty hospitals and those operated under government sponsorship or private entities, with over 500 hospital beds, accommodating both outpatients and inpatients. Generating substantial revenue, these hospitals boast advanced infrastructure, accommodating facilities for pelvic floor disorder diagnosis and monitoring, and highly equipped special operating rooms. They maintain close relationships with market suppliers, procuring medicinal products and consumables in large quantities. Additionally, they collaborate with reimbursement authorities and government organizations to ensure seamless patient care.

By End-user, Hospital  segment is expected to hold the largest market size for the year 2024

The Pelvic Floor Diagnostics Market's Ultrasound Systems segment is projected to expand significantly during the forecast period. This growth is attributed to the increasing utilization of ultrasound systems for imaging pelvic floor disorders. Pelvic floor ultrasound plays a crucial role in assessing the urethra and related structures, prolapse, and implant positioning. Advanced imaging techniques, such as multicompartment evaluation using transperineal, endovaginal, and endoanal scanning, offer comprehensive insights into pelvic floor conditions. The burgeoning patient population suffering from pelvic floor disorders, including urinary and fecal incontinence, stimulates the Ultrasound Systems segment's expansion.

North America is forecasted to hold the largest market size by region in 2024

The North American pelvic floor diagnostics market is projected to expand significantly during the forecast period. The United States, in particular, is the largest market within the North American region. Factors fueling this growth include an aging population, lifestyle modifications, and unhealthy diets leading to an increase in health issues and pelvic floor disorders such as urinary incontinence. The rise in instances of bladder dysfunction and urinary incontinence has subsequently boosted the demand for urodynamic monitoring, thereby driving the growth of the pelvic floor diagnostics market in North America.

The Pelvic Floor Diagnostics Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Alacer Biomedica
  • Cadwell Industries Inc.
  • Caldera Medical Inc.
  • Diversatek Inc.
  • FEMSelect Ltd.
  • GE Healthcare Technologies Inc.
  • Halo Medical Technologies
  • HC Italia srl
  • KARL STORZ SE and Co. KG
  • MEDKONSULT medical technology s. r. o
  • Medspira LLC
  • Medtronic Plc
  • Neurosoft
  • Noraxon USA Inc.
  • Renovia Inc.
  • SRS Medical
  • Stryker Corp.
  • THD S.p.A
  • The Cooper Companies Inc.

For insights on company offerings- Request a sample report!

Research Analysis Overview

The Pelvic Floor Diagnostics Market encompasses a range of technologies and diagnostic tests used to assess urethral functions, pelvic organ prolapse, fecal issues, and other pelvic floor dysfunctions. Urodynamics Systems and Ultrasound Systems are key technologies used in this market, providing valuable information on bladder and pelvic organ pressure, urinary incontinence, and abnormalities related to the uterus, bladder, and bowel. Urethral functions, bladder control, and the risk of prolapse are essential aspects of pelvic floor health. Pelvic organ prolapse, a medical condition that occurs when the pelvic organs, including the uterus, bowel, and bladder, descend from their normal positions, can be diagnosed through various noninvasive imaging techniques. Fecal issues, such as constipation and fecal incontinence, can also be assessed through diagnostic tests. Abnormalities in the pelvis, including the coccyx, pubic bone, ligaments, and muscles, can contribute to pelvic floor dysfunctions. Arthritis, injury, and aging are common risk factors for pelvic floor disorders. Regular exercise and maintaining pelvic floor muscle strength are essential for preventing and managing these conditions.

Market Research Overview

The Pelvic Floor Diagnostics Market encompasses a range of diagnostic tools and technologies used to assess various pelvic floor disorders in patients. These disorders include prolapse, urinary incontinence, faecal incontinence, and other pelvic organ disorders. Conservative treatments such as physical therapy and lifestyle changes are often the first line of defense, but when necessary, costly diagnostic tests are used to provide a comprehensive assessment. Telemedicine and remote consultations have become increasingly popular in pelvic floor diagnostics, allowing for continuous patient monitoring and early diagnoses. Diagnostic technology includes MRI technology, urodynamic systems, ultrasound machines, and instruments and equipment like catheterization kits and cystoscopes. Conditions such as prostate disorders, constipation, and voiding dysfunction are common in male and geriatric populations. Diagnostic centers provide initial evaluations and specialized care, with referrals for further treatment plans. Patient diagnostic tests include noninvasive imaging like ultrasound systems and diagnostic tests for fecal issues and abnormalities. Urological conditions like infections, tumors, and urinary tract issues require bladder visualization and pressure tests. Reimbursement structures and healthcare spending are significant considerations for market participants, with medical devices like urodynamics systems and anorectal manometry playing a key role. Pregnant women and expectant mothers also require pelvic floor diagnostics, with technical training and regional distributors ensuring access to diagnostic technology. Risk factors for pelvic floor disorders include arthritis, injury, obesity, and aging population. Regular exercise and pelvic floor rehabilitation are essential for maintaining pelvic floor health. Overall, the pelvic floor diagnostics market is a critical component of healthcare, ensuring accurate diagnoses and effective treatment plans for patients.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Read News Read Less
Interested in this report?
Get your sample now!